iDose® TR | Glaukos
iDose TR is the first-of-its-kind, long duration, anchored intracameral procedural pharmaceutical therapy for the treatment of OAG or OHT. It delivers continuous prostaglandin analog therapy …
IDose TR: Uses, Dosage, Side Effects, Warnings - Drugs.com
2024年3月26日 · iDose TR (travoprost) is a long-acting eye implant used for open-angle glaucoma or ocular hypertension to lower pressure within the eye. iDose TR works by slowly …
FDA批准曲伏前列素前房内植入物治疗青光眼、高眼压症 - 知乎
2023年12月15日 · iDose TR是一种含有75毫克曲伏前列素的无菌前房植入物。 它是一种首创、持续时间长的前房内手术药物疗法，旨在长时间持续将药物输送到眼内。 该疗法旨在通过解决 …
iDose® TR Prescribing Information - Glaukos
iDose TR is a travoprost delivery system consisting of a travoprost releasing implant pre-loaded in a sterile, single-dose inserter. iDose TR is administered intracamerally through a small, clear …
Welcome to iDose TR
Learn about iDose® TR (travoprost intracameral implant) 75 mcg—the convenient, FDA-approved treatment that helps lower eye pressure in most people with open-angle glaucoma or high eye …
FDA批准iDose TR(曲伏前列素前房内植入物)用于治疗青光眼和高 …
眼科医疗技术和制药公司Glaukos Corporation于12月14日宣布，美国食品药品监督管理局(FDA)已批准其前列腺素类似物iDose TR(曲伏前列素前房内植入物)75mcg的新药申请(NDA)，用于降 …
Glaukos iDose® TR (travoprost intracameral implant)—FDA …
iDose TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT). iDose TR …
iDose TR Overview - Glaukos iDose® TR
What is iDose TR? iDose TR is an FDA-approved, all-in-one prescription medicine and drug delivery system for lowering eye pressure. Barely visible to the human eye, iDose TR is a tiny …
About iDose® TR (travoprost intracameral implant) | Glaukos
iDose TR is a procedural pharmaceutical that delivers prostaglandin analog therapy for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. …
获批FDA！首款青光眼药物递送植入物！ - 网易
2024年1月1日 · 近日，眼科医疗技术兼制药公司Glaukos（纽约证券交易所代码：GKOS）宣布FDA已批准新药申请（NDA），该公司装载75微克曲伏前列素前房的iDose ® TR植入物可用 …